Lv4
768 积分 2024-04-28 加入
Simple quantitative haemolytic microassay for determination of complement alternative pathway activation (AP50)
16天前
已完结
Progress and promise of pharmacodynamic biomarkers: novel strategies and assay considerations in drug development
25天前
已完结
Accurate quantification of anti-drug antibodies against each unique Fab of a bispecific antibody using an ECL bridging assay
2个月前
已完结
Immunogenicity assay supporting clinical development of RGB-19, a proposed biosimilar to RoActemra®
3个月前
已完结
Streamlined neutralizing antibody assay development: overcoming serum interference, utilization of DOE and automation
3个月前
已完结
CD25: A potential tumor therapeutic target
4个月前
已完结
Strategies to Determine Assay Format for the Assessment of Neutralizing Antibody Responses to Biotherapeutics
5个月前
已完结
A Fit-for-purpose Strategy for Clinical Immunogenicity Assessment of Multivalent Bispecific Antibodies
5个月前
已完结
A Novel Neutralization Antibody Assay Method to Overcome Drug Interference with Better Compatibility with Acid-Sensitive Neutralizing Antibodies
5个月前
已完结
Lanadelumab: A Review in Hereditary Angioedema
5个月前
已完结
皖公网安备34019202002308
